Shimamoto, Y., Koizumi, K., Okabe, H., Kazuno, H., Murakami, Y., Nakagawa, F., . . . Fukushima, M. (2002). Sensitivity of Human Cancer Cells to the New Anticancer Ribo‐nucleoside TAS–106 Is Correlated with Expression of Uridine‐cytidine Kinase 2. Jpn J Cancer Res.
Chicago Style CitationShimamoto, Yuji, Katsuhisa Koizumi, Hiroyuki Okabe, Hiromi Kazuno, Yuko Murakami, Fumio Nakagawa, Akira Matsuda, Takuma Sasaki, i Masakazu Fukushima. "Sensitivity of Human Cancer Cells to the New Anticancer Ribo‐nucleoside TAS–106 Is Correlated With Expression of Uridine‐cytidine Kinase 2." Jpn J Cancer Res 2002.
Cita MLAShimamoto, Yuji, et al. "Sensitivity of Human Cancer Cells to the New Anticancer Ribo‐nucleoside TAS–106 Is Correlated With Expression of Uridine‐cytidine Kinase 2." Jpn J Cancer Res 2002.